Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

TCT Abstract Ranking Reveals Global CVD Research Hot Spots

L.A. McKeown

November 21, 2023

News Daily News

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Shelley Wood

August 15, 2022

JSousa1.cropped (002) in memoriam_header

News Daily News

Stent Pioneer José Eduardo Sousa Dies, Age 88

Shelley Wood

March 14, 2022

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Daily News

Cardiology Societies Unite to Condemn Racism and Health Inequality

L.A. McKeown

June 01, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March

Todd Neale

March 01, 2020

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

特朗普逆转获胜，美国心脏病学家也纷纷震惊

Todd Neale

November 09, 2016

News Daily News

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

Todd Neale

November 09, 2016

News Daily News

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

L.A. McKeown

June 03, 2015

News Daily News

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

L.A. McKeown

June 03, 2015

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

End-Diastolic FFR More Accurate than Conventional Version in Preclinical Study

February 12, 2014

Advertisement

TCT Abstract Ranking Reveals Global CVD Research Hot Spots

AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions

Stent Pioneer José Eduardo Sousa Dies, Age 88

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Cardiology Societies Unite to Condemn Racism and Health Inequality

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

COVID-19: TCTMD’s Daily Dispatch for March

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

特朗普逆转获胜，美国心脏病学家也纷纷震惊

Trump’s Unexpected Win Met With Everything From Shock to Optimism Among US Cardiologists

ISAR-DESIRE 3: Drug-Coated Balloon Shows Durable Antirestenotic Effect in DES Restenosis

ISAR-DESIRE 3：药物涂层球囊对 DES 再狭窄表现出持续抗再狭窄效应

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

End-Diastolic FFR More Accurate than Conventional Version in Preclinical Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content